276 related articles for article (PubMed ID: 6241847)
21. [In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].
Allocati N; Catamo G; Cellini L
Boll Soc Ital Biol Sper; 1984 Oct; 60(10):1927-33. PubMed ID: 6440583
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial resistance and minimum inhibitory concentrations of bacteria isolated from bustards in the United Arab Emirates.
Bailey TA; Silvanose C; Wernery U; Samour JH; Naldo J
Avian Dis; 1998; 42(4):690-7. PubMed ID: 9876837
[TBL] [Abstract][Full Text] [Related]
23. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim.
Chin NX; Neu HC
Antimicrob Agents Chemother; 1983 Nov; 24(5):754-63. PubMed ID: 6229216
[TBL] [Abstract][Full Text] [Related]
24. In vitro antimicrobial activity of diethyldithiocarbamate and dimethyldithiocarbamate against methicillin-resistant Staphylococcus.
Taylor EH; Walker EM; Bartelt M; Day S; Pappas AA
Ann Clin Lab Sci; 1987; 17(3):171-7. PubMed ID: 3037985
[TBL] [Abstract][Full Text] [Related]
25. [Study of the sensitivity to pipemidic acid, pefloxacin and norfloxacin of 444 bacterial strains isolated at a general hospital].
Berardi-Grassias LD; Roy O
Pathol Biol (Paris); 1987 May; 35(5):467-72. PubMed ID: 3112705
[TBL] [Abstract][Full Text] [Related]
26. Ofloxacin: antibacterial activity, induction of resistance and killing curves.
Husson MO; Izard D; Bryskier A; Leclerc H
Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716
[TBL] [Abstract][Full Text] [Related]
27. In vitro comparison of norfloxacin with nalidixic acid, cinoxacin and oxolinic acid.
Vuye A
Arzneimittelforschung; 1983; 33(12):1623-7. PubMed ID: 6230083
[TBL] [Abstract][Full Text] [Related]
28. In-vitro activity of ofloxacin, a quinolone carboxylic acid compared to other quinolones and other antimicrobial agents.
Kumada T; Neu HC
J Antimicrob Chemother; 1985 Nov; 16(5):563-74. PubMed ID: 3865923
[TBL] [Abstract][Full Text] [Related]
29. [Comparison of the in vitro activity of 6 quinolones on Pseudomonas sp].
Lesage D; Delisle-Mizon F; Vergez P; Daguet GL
Pathol Biol (Paris); 1985 May; 33(5):412-5. PubMed ID: 3162141
[TBL] [Abstract][Full Text] [Related]
30. In vitro activity of lomefloxacin (SC-47111; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones.
Chin NX; Novelli A; Neu HC
Antimicrob Agents Chemother; 1988 May; 32(5):656-62. PubMed ID: 3164987
[TBL] [Abstract][Full Text] [Related]
31. In vitro antibacterial activity of norfloxacin and other agents against ocular pathogens.
Shungu DL; Tutlane VK; Weinberg E; Gadebusch HH
Chemotherapy; 1985; 31(2):112-8. PubMed ID: 3157551
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of the antimicrobial activity of pefloxacin (1589 RB), nalidixic acid and flumequin (author's transl)].
Thabaut A; Durosoir JL
Pathol Biol (Paris); 1982 Jun; 30(6):394-7. PubMed ID: 6810283
[TBL] [Abstract][Full Text] [Related]
33. [In vitro antibacterial activity of a new fluoroquinolone, fleroxacin as a function of the sensitivity or resistance to nalidixic acid and to pefloxacin].
Soussy CJ; Leclercq R; Deforges L; Duval J
Pathol Biol (Paris); 1989 May; 37(5):364-9. PubMed ID: 2506511
[TBL] [Abstract][Full Text] [Related]
34. In vitro activity of pefloxacin.
Husson MO; Izard D; Bouillet L; Leclerc H
Drugs Exp Clin Res; 1986; 12(4):313-7. PubMed ID: 3522154
[TBL] [Abstract][Full Text] [Related]
35. In vitro activity of pefloxacin against gram-negative and gram-positive bacteria in comparison with other antibiotics.
Debbia E; Schito GC; Nicoletti G; Speciale A
Chemioterapia; 1987 Oct; 6(5):319-23. PubMed ID: 3480779
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
Diagn Microbiol Infect Dis; 2005 Jul; 52(3):187-93. PubMed ID: 16105563
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.
Mascellino MT; Farinelli S; Iegri F; Iona E; De Simone C
Drugs Exp Clin Res; 1998; 24(3):139-51. PubMed ID: 9825230
[TBL] [Abstract][Full Text] [Related]
38. [Growing incidence of nalidixic acid resistance and sensitivity to quinolones in Salmonella typhimurium strains isolated from man or animal].
Heurtin-Le Corre C; Donnio PY; Bonnier M; Travert MF; Lacourt A; Avril JL
Pathol Biol (Paris); 1998 Oct; 46(8):587-90. PubMed ID: 9871929
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Salmonella spp. with resistance to extended-spectrum cephalosporins and fluoroquinolones isolated in North America and Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2004).
Biedenbach DJ; Toleman M; Walsh TR; Jones RN
Diagn Microbiol Infect Dis; 2006 Jan; 54(1):13-21. PubMed ID: 16290025
[TBL] [Abstract][Full Text] [Related]
40. In vitro antimicrobial interactions of arthemeter with some 4-quinolones.
Esimone CO; Adikwu MU; Nwafor SV; Okoli CO; Ndu OO; Nwoke OI
Boll Chim Farm; 2002; 141(5):385-8. PubMed ID: 12481382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
